CNR1

CNR1

CNR1 詳細

Molecule Name
Cannabinoid CB1 receptor
分子の別称
CNR1,cannabinoid receptor 1,CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR
Drug Development Progress
治験薬の数38
市販薬剤の数2
研究&開発段階Approved
ターゲットの別称
Cannabinoid Receptor 1 (Brain),CNR1,Cannabinoid Receptor 1,CANN6,CB-R,CNR,CB1,Central Cannabinoid Receptor,CB1K5,CB1A,CB1R,Receptor, Cannabinoid, CB1
バックグランド
This gene encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene.

CNR1 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Dronabinol(AXIM Biotechnologies)Phase 3 ClinicalAxim Biotechnologies Inc
Anorexia Nervosa; Cachexia; Child Nutrition Disorders; Nausea; Neoplasms; Nutrition Disorders; Sarcopenia; Vomiting
詳細
Cannabidiol soft-gel (Avecho Biotechnology)CBD-TPMPhase 3 ClinicalAvecho Biotechnology Ltd
Sleep Initiation and Maintenance Disorders
詳細
Cannabidiol Gel (Zynerba)ZYN002; ZYN-002Phase 3 ClinicalZynerba Pharmaceuticals Inc
DiGeorge Syndrome; Fragile X Syndrome
詳細
AdezunapAP-707Phase 3 ClinicalCannaXan GmbH
Accidental Injuries; Back Pain; Brachial Plexus Neuropathies; Brain Injuries, Traumatic; Chronic Pain; Diabetes Mellitus; Diabetic Neuropathies; Diabetic peripheral neuropathy; Low Back Pain; Multiple Sclerosis; Neuralgia; Pain; Pain, Postoperative; Paraplegia; Peripheral Nerve Injuries; Peripheral Nervous System Diseases; Phantom Limb; Somatoform Disorders; Stroke
詳細
Dronabinol(Vertanical)VER-01Phase 3 ClinicalVertanical GmbH
Low Back Pain
詳細
cannabidiol (Cardiol Therapeutics)Phase 3 ClinicalCardiol Therapeutics Inc
Cardiovascular Diseases; Coronavirus Disease 2019 (COVID-19); Myocarditis; Pericarditis
詳細
SelonabantV-24343; ANEB-001; VER-24343Phase 2 ClinicalVernalis Plc
Obesity; Poisoning
詳細
11C-MePPEP11C-MePPEPPhase 2 ClinicalEli Lilly And Company
Obesity; Substance-Related Disorders
詳細
AX-1602AX-1602Phase 2 ClinicalAxim Biotechnologies Inc
Dermatitis, Atopic; Psoriasis; Vitiligo
詳細
NimacimabRYI-018; RYI-028; JNJ-2463Phase 2 ClinicalBird Rock Bio Inc
Diabetic Gastroparesis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity; Renal Insufficiency, Chronic
詳細
ART-2713NEO-1940; ART-2713; ART27.13; AZD-1940Phase 2 ClinicalAstrazeneca Plc, Neomed Inc, Pfizer Inc
Anorexia; Cachexia; Low Back Pain; Pain; Weight Loss
詳細
AEF-0217AEF-0217Phase 2 ClinicalAelis Farma
Down Syndrome
詳細
MonlunabantS-MRI-1891; (-)-MRI-1891; NN9440–INV-202; INV-202; MRI-1891Phase 2 ClinicalInversago Pharma Inc
Diabetic Nephropathies; Metabolic Diseases; Metabolic Syndrome; Obesity
詳細
Cannabidiol (Ananda Scientific)A-1002-N5S; A1002N5SPhase 2 ClinicalAnanda Scientific Inc
Chronic Pain; Opioid-Related Disorders; Stress Disorders, Post-Traumatic; Tobacco Smoking; Tobacco Use Disorder
詳細
Cannabidiol (Biopharmaceutical Research Company)BRC-001Phase 2 ClinicalBiopharmaceutical Research Company
Breast Neoplasms; Carcinoma, Ductal, Breast
詳細
C20T5C20T5Phase 2 ClinicalMurdoch Childrens Research Institute
詳細
C12T12C12T12Phase 2 ClinicalMurdoch Childrens Research Institute
詳細
SuvadronabinolTHC-VHS-NEC; SBI-100; NB-1111; Sb-100 OE; SBI-100 OE; THCVHS; THCVHS-N; THCVHS-NE; UM-5050Phase 2 ClinicalUniversity Of Mississippi
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
詳細
IGC-AD1IGC-AD1Phase 2 ClinicalUniversity Of South Florida
Alzheimer Disease; Dementia; Psychomotor Agitation
詳細
LixosiconeAEF-0117Phase 2 ClinicalAelis Farma, National Institute On Drug Abuse
Marijuana Abuse
詳細
ZYN-001ZYN-001Phase 1 ClinicalZynerba Pharmaceuticals
Fibromyalgia; Neuralgia
詳細
TetrahydrocannabivarinGWP-42004; THCV; O-4394; DELTA9-THCV; GW-42004Phase 1 ClinicalGw Pharmaceuticals Plc
Diabetes Mellitus, Type 2; Dyslipidemias; Hypercholesterolemia; Hyperglycemia; Metabolic Syndrome; Obesity, Morbid
詳細
Cannabidiol/hydroxychloroquineIHL-675A; IHL-675Phase 1 ClinicalIncannex Healthcare Ltd
Arthritis, Rheumatoid; Respiratory Distress Syndrome, Adult
詳細
ZevaquenabantMRI-1867; (S)-MRI-1867; INV-101Phase 1 ClinicalNational Institutes Of Health
Scleroderma, Systemic
詳細
Cannabidiol (Artelo Biosciences)ART-12.11; ART12.11; ART-1211Phase 1 ClinicalArtelo Biosciences Inc
Anxiety; Depression; Depressive Disorder
詳細
S1-221S1-221Phase 1 ClinicalDelphian Therapeutics Australia Pty Ltd
詳細
Cannabidiol (Tiamat Australia)MRX-1Phase 1 ClinicalTiamat Australia Pty Ltd
詳細
Atorvastatin Calcium Hydrate/CannabidiolPhase 1 ClinicalIndication Bioscience LLC
Coronary Disease; Dyslipidemias
詳細
TPT0301TPT-0301; TPT0301Phase 1 ClinicalTetra Pharm Technologies ApS
Chronic Pain
詳細
INV-347NN9441; NN-9441; INV-347Phase 1 ClinicalInversago Pharma Inc
Obesity
詳細
IPI 201(Isosceles Pharmaceuticals Inc )IPI-201Phase 1 Clinical
Pain, Postoperative
詳細
CRB-913CRB-913Phase 1 ClinicalJenrin Discovery LLC
Obesity
詳細
GFB-024Phase 1 ClinicalTakeda Pharma
Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Endocrine System Diseases; Kidney Diseases
詳細
DBPR-211Phase 1 ClinicalNational Health Research Institutes
Diabetes Mellitus, Type 2
詳細
MP-10XMP-10XClinicalMedipure Holdings
Pain
詳細
MP-20XMP-20XClinicalMedipure Holdings
Anxiety Disorders; Mood Disorders
詳細
Cannabidiol (Receptor Life Sciences)ClinicalReceptor Life Sciences Inc
Autism Spectrum Disorder
詳細
Cannabidiol/PalmitoylethanolamideSCI–210; THX-210ClinicalTherapix Biosciences Ltd
Autism Spectrum Disorder; Diabetic Neuropathies
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Cannabidiol/Dronabinoldelta-9-THC/CBD; MPL-001; MPL-005; PPP-011; BOL-DP-o-04; GW-1000-02; PPP-001; MGC-ODT; GW-1000; KL16-012; THC-5ApprovedGw PharmaceuticalsSativex, Qixleef, QIXLEEFTMCanadaCancer Pain; Chronic Pain; Muscle Spasticity; Neuralgia; Multiple Sclerosisnull2005-04-01
Acute Pain; Agitation; Agoraphobia; Anorexia; Anxiety Disorders; Arthritis, Psoriatic; Arthritis, Rheumatoid; Back Pain; Cancer Pain; Cerebral Palsy; Chronic Pain; Corticobasal degeneration; Dementia; Depression; Depressive Disorder, Major; Diabetic Neuropathies; Drug Resistant Epilepsy; Essential Tremor; Genital Diseases, Male; Healthy Aging; Hepatic Insufficiency; Hidradenitis Suppurativa; Huntington Disease; Kidney Diseases; Low Back Pain; Malnutrition; Marijuana Abuse; Marijuana Use; Migraine Disorders; Multiple Sclerosis; Muscle Spasticity; Neck Pain; Neoplasms; Neuralgia; Neuralgia, Postherpetic; Neuromyelitis Optica; Opioid-Related Disorders; Osteoarthritis, Knee; Pain; Panic Disorder; Peripheral Nervous System Diseases; Phobia, Social; Psoriasis; Reflex Sympathetic Dystrophy; Renal Insufficiency; Renal Insufficiency, Chronic; Sciatica; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Social Behavior; Spasm; Spinal Cord Injuries; Squamous Cell Carcinoma of Head and Neck; Stress Disorde
詳細
CannabidiolCHI-902; APH-1501; GLA-015; BTX-1503; BTX-1801; GWP-42003-P; BOL-DP-o-05; GW-42003; BTX-1204; PTL-101; BTX-1702; PBX-1308; BRCX-014; LYT-310; GWP-42003ApprovedGw Pharmaceuticals PlcEpidyolex, Cannepil, EpidiolexUnited StatesEpilepsies, Myoclonic; Lennox Gastaut Syndromenull2018-06-25
Acne Vulgaris; Acute Pain; Alcohol Abstinence; Alcoholic Intoxication; Alcoholism; Anemia, Sickle Cell; Anorexia Nervosa; Anxiety; Anxiety Disorders; Appetitive Behavior; Arthralgia; Arthritis, Psoriatic; Arthritis, Rheumatoid; Autism Spectrum Disorder; Autistic Disorder; Azotemia; Behavior, Addictive; Bipolar Disorder; Blepharospasm; Brain Diseases; Brain Injuries, Traumatic; Breast Neoplasms; Bruxism; Burnout, Psychological; Cachexia; Carcinoma, Non-Small-Cell Lung; Carpal Tunnel Syndrome; Central Nervous System Diseases; Child Behavior Disorders; Chronic Pain; Chronic Periodontitis; Chronic Urticaria; Cicatrix; Cognition Disorders; Cognitive Dysfunction; Colitis, Ulcerative; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Corticobasal degeneration; Craving; Crohn Disease; Cystitis, Interstitial; Dentin Sensitivity; Depression; Dermatitis, Atopic; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Driving Under the Influence; Drug Resistant Epilepsy; Dyslipidemias; Dysmenorrhea; Dyspepsia; Eczema;
詳細